CONMED Corporation - Asset Resilience Ratio
CONMED Corporation (CNMD) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is CONMED Corporation's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2017)
This chart shows how CONMED Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CONMED Corporation asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down CONMED Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CONMED Corporation debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: CONMED Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
CONMED Corporation Industry Peers by Asset Resilience Ratio
Compare CONMED Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Mediantechn
PA:ALMDT |
Medical Devices | 0.45% |
Annual Asset Resilience Ratio for CONMED Corporation (2011–2017)
The table below shows the annual Asset Resilience Ratio data for CONMED Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $1.36 Billion | -- |
| 2016-12-31 | 0.00% | $0.00 | $1.33 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $1.11 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $1.10 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $1.09 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $1.08 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $935.59 Million | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more